Edwards Lifesciences Revenues Trend

EW -- USA Stock  

USD 149.81  2.81  1.84%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Revenues of Edwards Lifesciences Corporation with missing and latest data points interpolated. Revenues refers to the total amount of money received by Edwards Lifesciences for goods sold or services provided during a certain time period. It also includes all of Edwards Lifesciences sales as well as any other increase in Edwards Lifesciences Corporation equity.Revenues are reported on Edwards Lifesciences income statement and calculated before any expenses are subtracted. Amount of Revenue recognized from goods sold

3.45 B

          10 Years Trend
Slightly volatile

Regression Statistics

Arithmetic Mean  2,042,991,667
Geometric Mean  1,873,936,424
Coefficient Of Variation  40.31
Mean Deviation  663,591,667
Median  2,045,500,000
Standard Deviation  823,474,850
Range  2,757,900,000
R Value  0.99
R Squared  0.98
Significance  0
Slope  226,151,399

Edwards Lifesciences Revenues Over Time

2016-12-31  2,963,700,000 
2017-12-31  2,963,700,000 
2018-12-31  3,450,000,000 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Edwards Lifesciences Upcoming Company Events

Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 25, 2017
Additionally see analysis of Edwards Lifesciences Correlation with competitors. Please also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.